Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 10/20 | 0.64 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.60 |
| ▸ | USP2 | O75604 | 4/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14934575 | 0.89 | EPHX2 (0.66) | EPHX2TRPV1USP2CYP3A4TSHR | |
| SCHEMBL14934568 | 0.87 | EPHX2 (0.63) | EPHX2TRPV1USP2CYP3A4TSHR | |
| SCHEMBL14934398 | 0.86 | EPHX2 (0.79) | EPHX2USP2CYP3A4TSHRCYP1A2 | |
| SCHEMBL14934408 | 0.83 | EPHX2 (0.63) | EPHX2TRPV1USP2CYP3A4TSHR | |
| SCHEMBL14934435 | 0.82 | EPHX2 (0.64) | EPHX2TRPV1USP2CYP3A4TSHR | |
| SCHEMBL14934413 | 0.81 | EPHX2 (0.78) | EPHX2USP2CYP3A4TSHRCYP1A2 | |
| SCHEMBL14934446 | 0.81 | EPHX2 (0.79) | EPHX2TRPV1USP2CYP3A4TSHR | |
| SCHEMBL14934434 | 0.81 | EPHX2 (0.59) | EPHX2TRPV1USP2CYP3A4TSHR | |
| SCHEMBL2723773 | 0.80 | TRPV1 (0.79) | TRPV1 | |
| SCHEMBL14934415 | 0.79 | CYP1A2 (0.71) | EPHX2USP2CYP3A4TSHRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013065712-A1 | DIAZASPIROUREA DERIVATIVE AND PHARMACEUTICAL USE THEREOF | 東レ株式会社 (JP) | 2013-05-10 | — | — | WO | disclosed |